US6828431B1
(en)
*
|
1999-04-09 |
2004-12-07 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of breast cancer
|
US7241876B2
(en)
|
1996-01-11 |
2007-07-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of breast cancer
|
US6329505B1
(en)
|
1997-02-25 |
2001-12-11 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
US6657056B2
(en)
|
1997-02-25 |
2003-12-02 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US6465611B1
(en)
|
1997-02-25 |
2002-10-15 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US20030185830A1
(en)
|
1997-02-25 |
2003-10-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6800746B2
(en)
|
1997-02-25 |
2004-10-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7033827B2
(en)
|
1997-02-25 |
2006-04-25 |
Corixa Corporation |
Prostate-specific polynucleotide compositions
|
US6630305B1
(en)
|
1999-11-12 |
2003-10-07 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6759515B1
(en)
|
1997-02-25 |
2004-07-06 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6620922B1
(en)
|
1997-02-25 |
2003-09-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6943236B2
(en)
|
1997-02-25 |
2005-09-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6894146B1
(en)
|
1997-02-25 |
2005-05-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7202342B1
(en)
|
1999-11-12 |
2007-04-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6818751B1
(en)
|
1997-08-01 |
2004-11-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7517952B1
(en)
|
1997-02-25 |
2009-04-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
CA2286304C
(en)
|
1997-04-10 |
2007-08-07 |
Diagnocure Inc. |
Pca3, pca3 genes, and methods of use
|
US6365369B1
(en)
|
1998-04-01 |
2002-04-02 |
Human Genome Sciences, Inc. |
Prostate specific secreted protein
|
US6861215B1
(en)
|
1998-05-21 |
2005-03-01 |
Diadexus, Inc. |
Method of diagnosing, monitoring, and staging prostate cancer
|
US20040141975A1
(en)
|
1998-06-01 |
2004-07-22 |
Raitano Arthur B. |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
ATE437947T1
(de)
|
1998-06-01 |
2009-08-15 |
Agensys Inc |
Serpentintransmembranantigene exprimiert in menschlichem krebs und deren verwendungen
|
US20060052321A1
(en)
|
2002-04-05 |
2006-03-09 |
Raitano Arthur B |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
US7037667B1
(en)
|
1998-06-01 |
2006-05-02 |
Agensys, Inc. |
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
|
WO2000020584A2
(en)
*
|
1998-10-02 |
2000-04-13 |
Urogenesys, Inc. |
Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
|
US6902892B1
(en)
|
1998-10-19 |
2005-06-07 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
US6528054B1
(en)
*
|
1998-12-28 |
2003-03-04 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of breast cancer
|
PL350863A1
(en)
*
|
1999-04-09 |
2003-02-10 |
Corixa Corp |
Compositions and methods for the treatment and diagnosis of breast cancer
|
US6943235B1
(en)
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
AU4484400A
(en)
*
|
1999-04-23 |
2000-11-10 |
University Of Washington |
Prostate-specific polynucleotides, polypeptides and their methods of use
|
AU5416700A
(en)
*
|
1999-05-20 |
2000-12-12 |
Fahri Saatcioglu |
Differentially expressed genes in prostate cancer
|
WO2001004143A2
(en)
*
|
1999-07-13 |
2001-01-18 |
Smithkline Beecham Biologicals S.A. |
Prostase vaccine
|
EP1222266B1
(en)
|
1999-09-29 |
2006-03-29 |
Diagnocure Inc. |
Pca3 messenger rna in benign and malignant prostate tissues
|
AU7917200A
(en)
|
1999-09-30 |
2001-04-30 |
Institut Pasteur |
Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences
|
WO2001025272A2
(en)
*
|
1999-10-04 |
2001-04-12 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
IL147952A0
(en)
*
|
1999-10-05 |
2002-08-14 |
Agensys Inc |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
|
US6790631B1
(en)
|
1999-10-05 |
2004-09-14 |
Agensys, Inc. |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
|
US7208280B2
(en)
|
1999-10-05 |
2007-04-24 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
EP1220931A1
(en)
*
|
1999-10-07 |
2002-07-10 |
Schering Aktiengesellschaft |
Dna encoding prost 07 polypeptide
|
EP1230364A2
(en)
*
|
1999-11-12 |
2002-08-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US20020048777A1
(en)
|
1999-12-06 |
2002-04-25 |
Shujath Ali |
Method of diagnosing monitoring, staging, imaging and treating prostate cancer
|
HUP0203968A3
(en)
*
|
2000-01-14 |
2004-09-28 |
Corixa Corp Seattle |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
WO2001059110A2
(en)
*
|
2000-02-08 |
2001-08-16 |
Agensys, Inc. |
34p3d7: a tissue specific protein highly expressed in prostate cancer
|
WO2001060860A2
(en)
*
|
2000-02-17 |
2001-08-23 |
Millennium Predictive Medicine, Inc. |
Genes differentially expressed in human prostate cancer and their use
|
WO2001070979A2
(en)
*
|
2000-03-21 |
2001-09-27 |
Millennium Pharmaceuticals, Inc. |
Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
|
US7611892B2
(en)
|
2000-03-24 |
2009-11-03 |
President And Fellows Of Harvard College |
Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
|
AU2001249549A1
(en)
*
|
2000-03-27 |
2001-10-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
GB0015722D0
(en)
*
|
2000-06-27 |
2000-08-16 |
Smithkline Beecham Sa |
Vaccine
|
GB0015736D0
(en)
*
|
2000-06-27 |
2000-08-16 |
Smithkline Beecham Biolog |
Vaccine
|
PT2266603E
(pt)
|
2000-10-18 |
2012-11-02 |
Glaxosmithkline Biolog Sa |
Vacinas tumorais
|
US7048931B1
(en)
|
2000-11-09 |
2006-05-23 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
WO2002044418A2
(en)
|
2000-11-28 |
2002-06-06 |
Wyeth |
Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
NZ526617A
(en)
|
2000-11-28 |
2004-09-24 |
Wyeth Corp |
Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
CA2443123A1
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
WO2002089747A2
(en)
*
|
2001-05-09 |
2002-11-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6897024B2
(en)
|
2001-05-31 |
2005-05-24 |
Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen |
Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
WO2003022995A2
(en)
|
2001-09-06 |
2003-03-20 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
|
CA2480811A1
(en)
*
|
2002-04-01 |
2003-10-16 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
|
EP1511768B1
(en)
*
|
2002-06-11 |
2007-04-11 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic compositions
|
CA2487907A1
(en)
*
|
2002-06-11 |
2003-12-18 |
Glaxosmithkline Biologicals S.A. |
Immunogenic compositions comprising a xenogenic prostate protein p501s
|
US20040081653A1
(en)
|
2002-08-16 |
2004-04-29 |
Raitano Arthur B. |
Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
|
CA2513780C
(en)
|
2003-02-07 |
2014-12-30 |
Diagnocure Inc. |
Method to detect prostate cancer from a urine sample
|
AU2004263274B2
(en)
|
2003-07-21 |
2009-11-05 |
Transgene S.A. |
Novel multifunctional cytokines
|
NZ550816A
(en)
|
2004-04-22 |
2009-12-24 |
Agensys Inc |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
CA2491067A1
(en)
|
2004-12-24 |
2006-06-24 |
Stichting Katholieke Universiteit |
Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
|
US9957569B2
(en)
|
2005-09-12 |
2018-05-01 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
DE06814528T1
(de)
|
2005-09-12 |
2012-01-05 |
The Regent Of The University Of Michigan |
Wiederkehrende genfusionen bei prostatakrebs
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
WO2008016111A1
(en)
|
2006-08-04 |
2008-02-07 |
Ajinomoto Co., Inc. |
Method for evaluation of lung cancer, lung cancer evaluation apparatus, lung cancer evaluation method, lung cancer evaluation system, lung cancer evaluation program, and recording medium
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
TR201807756T4
(tr)
|
2006-09-26 |
2018-06-21 |
Infectious Disease Res Inst |
Sentetik adjuvan içeren aşı bileşimi.
|
RU2639543C9
(ru)
|
2006-10-27 |
2018-06-14 |
Дженентек, Инк. |
Антитела и иммуноконъюгаты и их применения
|
JP5746811B2
(ja)
|
2006-12-21 |
2015-07-08 |
味の素株式会社 |
大腸癌の評価方法、ならびに大腸癌評価装置、大腸癌評価方法、大腸癌評価システム、大腸癌評価プログラムおよび記録媒体
|
WO2008075662A1
(ja)
|
2006-12-21 |
2008-06-26 |
Ajinomoto Co., Inc. |
乳癌の評価方法、ならびに乳癌評価装置、乳癌評価方法、乳癌評価システム、乳癌評価プログラムおよび記録媒体
|
EP2171094B1
(en)
|
2007-07-06 |
2011-11-16 |
The Regents of the University of Michigan |
Mipol1-etv1 gene rearrangements
|
US8106037B2
(en)
|
2007-08-03 |
2012-01-31 |
The Brigham And Women's Hospital, Inc. |
Identification and treatment of estrogen responsive prostate tumors
|
KR100976218B1
(ko)
|
2008-05-26 |
2010-08-17 |
한국표준과학연구원 |
비행시간이차이온질량분광법을 이용한 질병의 진단 방법,질병 지표의 스크린 방법, 및 질병 지표
|
JP5754137B2
(ja)
|
2008-06-20 |
2015-07-29 |
味の素株式会社 |
前立腺癌の評価方法、前立腺癌評価装置、前立腺癌評価方法、前立腺癌評価プログラム、記録媒体、前立腺癌評価システム、および情報通信端末装置
|
HUE027332T2
(en)
|
2008-08-05 |
2016-09-28 |
Toray Industries |
Cancer Detection Method
|
PL2324842T3
(pl)
*
|
2008-08-05 |
2015-08-31 |
Toray Industries |
Środek indukujący odporność
|
PL2322221T3
(pl)
|
2008-08-05 |
2015-01-30 |
Toray Industries |
Kompozycja farmaceutyczna do leczenia i zapobiegania raka
|
BRPI1007704A2
(pt)
*
|
2009-05-12 |
2019-12-03 |
Koninl Philips Electronics Nv |
fosfodiesterase 4d7 (pde4d7), para uso como um marcador para câncer de próstata maligno, sensível a hormônio; composição ou método de aquisição de dados ou imunoensaio para diagnosticar, detectar, monitorar ou prognosticar câncer de prostata maligno, sensível ao hormônio ou para diagnosticar, detectar, monitorar ou prognosticar a progressão para câncer de próstata maligno, sensível a hormônio; uso de pde4d7; imunoensaio para discriminar entre um tumor de próstata benigno e um câncer de próstata maligno, sensível a hormônio; método para identificar um indivíduo para elegibilidade para terapia contra câncer de próstata maligno, sensível a hormônio; imunoensaio para classificar um indivíduo ou corte de indivíduos com uma doença de câncer de próstata maligno, sensível a hormônio; composição farmacêutica inibitória para o tratamento ou prevenção de câncer de próstata maligno, sensível a hormônio; composição farmacêutica estimulatória; e; uso de um anticorpo específico para a proteína pde4d7 e/ou uma variante de anticorpo específica para a proteína pde4d7
|
EP2437753B1
(en)
|
2009-06-05 |
2016-08-31 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants and vaccine compositions containing them
|
JP5800817B2
(ja)
|
2009-09-17 |
2015-10-28 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
前立腺癌における再発性遺伝子融合
|
US9180187B2
(en)
|
2010-02-04 |
2015-11-10 |
Toray Industries, Inc. |
Medicament for treating and/or preventing cancer
|
PT2532743E
(pt)
|
2010-02-04 |
2015-08-04 |
Toray Industries |
Composição farmacêutica para o tratamento e/ou a prevenção de cancro
|
ES2583627T3
(es)
|
2010-02-04 |
2016-09-21 |
Toray Industries, Inc. |
Composición farmacéutica para el tratamiento y/o la prevención del cáncer
|
PL2532366T3
(pl)
|
2010-02-04 |
2017-02-28 |
Toray Industries, Inc. |
Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi
|
ES2583777T3
(es)
|
2010-02-04 |
2016-09-22 |
Toray Industries, Inc. |
Composición farmacéutica que comprende anticuerpos anti CAPRIN-1 para el tratamiento y/o la prevención del cáncer
|
US8945556B2
(en)
|
2010-11-19 |
2015-02-03 |
The Regents Of The University Of Michigan |
RAF gene fusions
|
BR112013020875A2
(pt)
|
2011-02-15 |
2019-09-24 |
Immune Design Corp |
método para indução de uma resposta imune específica para um imunógeno em um indivíduo.
|
AU2012243039B2
(en)
|
2011-04-08 |
2017-07-13 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
TR201802089T4
(tr)
|
2011-08-04 |
2018-03-21 |
Toray Industries |
Kanserin tedavisi ve/veya önlenmesi amacına yönelik ilaç bileşimi.
|
ES2763122T3
(es)
|
2011-08-04 |
2020-05-27 |
Toray Industries |
Composición farmacéutica, que comprende anticuerpos contra caprin 1 para el tratamiento y/o para la prevención del cáncer
|
KR101980554B1
(ko)
|
2011-08-04 |
2019-05-21 |
도레이 카부시키가이샤 |
암의 치료 및/또는 예방용 의약 조성물
|
MX348581B
(es)
|
2011-08-04 |
2017-06-20 |
Toray Industries |
Composicion farmaceutica para el tratamiento y/o prevencion de cancer.
|
AU2012290949B2
(en)
|
2011-08-04 |
2017-03-02 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
|
RU2624040C2
(ru)
|
2011-08-04 |
2017-06-30 |
Торэй Индастриз, Инк. |
Способ обнаружения рака поджелудочной железы
|
TR201808595T4
(tr)
|
2011-08-04 |
2018-07-23 |
Toray Industries |
Kanser hastalıklarının tedavisi ve/veya profilaksisi için farmasötik bileşim.
|
CN104363892A
(zh)
|
2012-02-07 |
2015-02-18 |
传染性疾病研究院 |
包含tlr4激动剂的改进佐剂制剂及其使用方法
|
PT2824114T
(pt)
|
2012-02-21 |
2019-08-05 |
Toray Industries |
Composição farmacêutica para o tratamento do cancro
|
RU2631804C2
(ru)
|
2012-02-21 |
2017-09-26 |
Торэй Индастриз, Инк. |
Фармацевтическая композиция для лечения или профилактики рака
|
CA2864864C
(en)
|
2012-02-21 |
2020-05-12 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
PL2818481T3
(pl)
|
2012-02-21 |
2020-02-28 |
Toray Industries, Inc. |
Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi złośliwemu
|
ES2656620T3
(es)
|
2012-03-30 |
2018-02-27 |
Toray Industries, Inc. |
Composición farmacéutica para el tratamiento y/o la prevención del cáncer de hígado
|
PL2832366T3
(pl)
|
2012-03-30 |
2018-04-30 |
Toray Industries, Inc. |
Kompozycja farmaceutyczna do leczenia i/lub zapobiegania rakowi pęcherzyka żółciowego
|
RS57420B1
(sr)
|
2012-05-16 |
2018-09-28 |
Immune Design Corp |
Vakcine za hsv-2
|
EP2855666B1
(en)
*
|
2012-05-25 |
2019-12-04 |
Cellectis |
Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cells
|
PL2876446T3
(pl)
|
2012-07-19 |
2019-06-28 |
Toray Industries, Inc. |
Sposób wykrywania nowotworu
|
PL2876447T3
(pl)
|
2012-07-19 |
2020-05-18 |
Toray Industries, Inc. |
Sposób wykrywania nowotworu
|
MX362912B
(es)
*
|
2012-09-11 |
2019-02-22 |
Oncotherapy Science Inc |
Péptidos ube2t y vacunas que incluyen los mismos.
|
WO2014066443A1
(en)
|
2012-10-23 |
2014-05-01 |
Emory University |
Gm-csf and il-4 conjugates, compositions, and methods related thereto
|
CA2909221A1
(en)
|
2013-04-18 |
2014-10-23 |
Immune Design Corp. |
Gla monotherapy for use in cancer treatment
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
US9862774B2
(en)
|
2013-08-09 |
2018-01-09 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
US11801223B2
(en)
|
2013-12-31 |
2023-10-31 |
Access To Advanced Health Institute |
Single vial vaccine formulations
|
WO2016011083A1
(en)
|
2014-07-15 |
2016-01-21 |
Immune Design Corp. |
Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector
|
JOP20200228A1
(ar)
*
|
2015-12-21 |
2017-06-16 |
Novartis Ag |
تركيبات وطرق لخفض تعبير البروتين tau
|
CN108472350A
(zh)
*
|
2016-01-08 |
2018-08-31 |
瓦西博迪公司 |
新表位rna癌症疫苗
|
CN109312402A
(zh)
|
2016-04-11 |
2019-02-05 |
得克萨斯州大学系统董事会 |
用于检测单个t细胞受体亲和力和序列的方法和组合物
|
IL314130A
(en)
|
2016-05-16 |
2024-09-01 |
Access To Advanced Health Inst |
Formulation containing a TLR agonist and methods of use
|
CN109562057A
(zh)
|
2016-05-16 |
2019-04-02 |
传染病研究所 |
聚乙二醇化脂质体和使用方法
|
BR112018074352B1
(pt)
|
2016-06-01 |
2021-11-30 |
Infectious Disease Research Institute |
Partículas de nanoalume contendo um agente de dimensionamento
|
JP7247101B2
(ja)
|
2017-04-03 |
2023-03-28 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
Steap-1に結合する抗体
|
KR102673794B1
(ko)
|
2017-06-15 |
2024-06-11 |
액세스 투 어드밴스드 헬스 인스티튜트 |
나노구조 지질 담체 및 안정적인 에멀션 그리고 이들의 용도
|
CN111315406A
(zh)
|
2017-09-08 |
2020-06-19 |
传染病研究所 |
包括皂苷的脂质体调配物及其使用方法
|
CN113874512A
(zh)
*
|
2018-11-07 |
2021-12-31 |
阿库斯股份有限公司 |
诱导毛细胞分化的组合物和方法
|
CN111000858B
(zh)
*
|
2019-05-10 |
2021-04-09 |
常州市第二人民医院 |
Nupr1抑制剂在制备膀胱癌治疗药物中的用途
|
CN114340665A
(zh)
|
2019-05-25 |
2022-04-12 |
传染病研究所 |
用于对佐剂疫苗乳剂进行喷雾干燥的组合物和方法
|
CN111968751B
(zh)
*
|
2020-06-29 |
2021-10-19 |
金电联行(北京)信息技术有限公司 |
一种使用多基线校正模型的传染病趋势预测方法与系统
|
AU2021337493A1
(en)
|
2020-09-04 |
2023-05-18 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
US20230310569A1
(en)
|
2020-09-04 |
2023-10-05 |
Access To Advanced Health Institute |
Genetically-adjuvanted rna vaccines
|
US20240050561A1
(en)
|
2020-12-23 |
2024-02-15 |
Access To Advanced Health Institute |
Solanesol vaccine adjuvants and methods of preparing same
|
WO2024052882A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
Immunogenic vaccine composition incorporating a saponin
|